Nov 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2020 Sep 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 26.81 30.32 61.00
(-11.6 pct) (-0.5 pct) (+0.9 pct)
Operating 1.39 1.74 4.30
(-20.2 pct) (-16.0 pct) (+5.0 pct)
Recurring 1.10 1.63 3.90
(-32.6 pct) (-15.0 pct) (+0.5 pct)
Net 1.22 1.23 3.30
(-1.0 pct) (-46.0 pct) (+12.8 pct)
EPS 26.36 yen 26.16 yen 71.47 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T